Enzyme Solutions, Inc. – Trademark Portfolio
Entity Type: 03
Enzyme Solutions, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. The portfolio also extends into Class 21 (Housewares) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ENZYME MAGIC, SAFER CHEMISTRY, ENZYME SOLUTIONS, and NATURALLY IT'S CLEAN. The owner is based in Garrett, IN.
2105 Forrest Park Drive
Garrett, IN 46738
Showing of trademarks Trademarks
Trademark Classifications
Enzyme Solutions, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Enzyme Solutions, Inc. have?
Enzyme Solutions, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 abandoned, 1 cancelled.
What trademark classes does Enzyme Solutions, Inc. file in?
Enzyme Solutions, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Enzyme Solutions, Inc.'s most well-known trademarks?
Enzyme Solutions, Inc.'s registered trademark portfolio includes well-known marks such as ENZYME MAGIC, SAFER CHEMISTRY, ENZYME SOLUTIONS, and NATURALLY IT'S CLEAN. These are among 4 currently registered trademarks in the portfolio.
What is Enzyme Solutions, Inc.'s trademark registration success rate?
Enzyme Solutions, Inc. has a 44% trademark registration rate, with 4 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.